Association of Two Polymorphisms in CCL2 With Parkinson's Disease: A Case-Control Study

Background: Parkinson's disease (PD) is the most common neurodegenerative movement disorder that is known to be related to neuro-inflammation. Chemokines participate in this process usually through upregulation of expression levels, which are closely related to the polymorphisms in their genes....

Full description

Bibliographic Details
Main Authors: Ruinan Shen, Suzhen Lin, Lu He, Xue Zhu, Zhekun Zhou, Shengdi Chen, Ying Wang, Jianqing Ding
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-01-01
Series:Frontiers in Neurology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fneur.2019.00035/full
_version_ 1818933071919972352
author Ruinan Shen
Suzhen Lin
Lu He
Xue Zhu
Zhekun Zhou
Shengdi Chen
Ying Wang
Jianqing Ding
author_facet Ruinan Shen
Suzhen Lin
Lu He
Xue Zhu
Zhekun Zhou
Shengdi Chen
Ying Wang
Jianqing Ding
author_sort Ruinan Shen
collection DOAJ
description Background: Parkinson's disease (PD) is the most common neurodegenerative movement disorder that is known to be related to neuro-inflammation. Chemokines participate in this process usually through upregulation of expression levels, which are closely related to the polymorphisms in their genes. Recent studies have further revealed the association between these polymorphisms and the risk of PD in multiple populations, but not the Chinese Han population.Methods:The promoter region of CCL2 was sequenced in 411 PD patients and 422 gender-age matched control from a Chinese Han population using PCR-RFLP method. Their genotype frequencies were analyzed statistically. Dual-luciferase reporter assays were conducted in neuroblastoma cells to assess the promoter transcriptional activity of the rs1024611 variants (T>C) and the GRCh38.p12chr17:34252593 G>C alleles in CCL2.Results:We found that the frequency of the CCL2 genotype of rs1024611 was significantly different between the PD and control groups (p = 0.021), while the C allele was associated with a significantly increased risk in the PD group (p = 0.004). Moreover, C allele of this newly identified alteration in CCL2 (GRCh38.p12chr17:34252593 G>C) was also found to be associated with an increased risk of PD (P genotype = 0.006, P allele = 0.006). Dual-luciferase reporter assay results indicated that rs1024611 C allele and GRCh38.p12chr17:.34252593 C allele increased the transcriptional activity of the CCL2 promoter.Conclusions: We, for the first time, report a risk polymorphism (rs1024611) and a new locus (GRCh38.p12chr17:.34252593 G>C) on CCL2, both of which are suggested as risk factors for PD in a Chinese Han population.
first_indexed 2024-12-20T04:42:33Z
format Article
id doaj.art-6d028a9f88844f6f8c0014564f723fa6
institution Directory Open Access Journal
issn 1664-2295
language English
last_indexed 2024-12-20T04:42:33Z
publishDate 2019-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Neurology
spelling doaj.art-6d028a9f88844f6f8c0014564f723fa62022-12-21T19:53:05ZengFrontiers Media S.A.Frontiers in Neurology1664-22952019-01-011010.3389/fneur.2019.00035396796Association of Two Polymorphisms in CCL2 With Parkinson's Disease: A Case-Control StudyRuinan Shen0Suzhen Lin1Lu He2Xue Zhu3Zhekun Zhou4Shengdi Chen5Ying Wang6Jianqing Ding7Institute of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaInstitute of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaInstitute of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaShanghai Jiaotong University School of Medicine, Shanghai, ChinaShanghai Jiaotong University School of Medicine, Shanghai, ChinaInstitute of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaInstitute of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaInstitute of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaBackground: Parkinson's disease (PD) is the most common neurodegenerative movement disorder that is known to be related to neuro-inflammation. Chemokines participate in this process usually through upregulation of expression levels, which are closely related to the polymorphisms in their genes. Recent studies have further revealed the association between these polymorphisms and the risk of PD in multiple populations, but not the Chinese Han population.Methods:The promoter region of CCL2 was sequenced in 411 PD patients and 422 gender-age matched control from a Chinese Han population using PCR-RFLP method. Their genotype frequencies were analyzed statistically. Dual-luciferase reporter assays were conducted in neuroblastoma cells to assess the promoter transcriptional activity of the rs1024611 variants (T>C) and the GRCh38.p12chr17:34252593 G>C alleles in CCL2.Results:We found that the frequency of the CCL2 genotype of rs1024611 was significantly different between the PD and control groups (p = 0.021), while the C allele was associated with a significantly increased risk in the PD group (p = 0.004). Moreover, C allele of this newly identified alteration in CCL2 (GRCh38.p12chr17:34252593 G>C) was also found to be associated with an increased risk of PD (P genotype = 0.006, P allele = 0.006). Dual-luciferase reporter assay results indicated that rs1024611 C allele and GRCh38.p12chr17:.34252593 C allele increased the transcriptional activity of the CCL2 promoter.Conclusions: We, for the first time, report a risk polymorphism (rs1024611) and a new locus (GRCh38.p12chr17:.34252593 G>C) on CCL2, both of which are suggested as risk factors for PD in a Chinese Han population.https://www.frontiersin.org/article/10.3389/fneur.2019.00035/fullCCL2polymorphismParkinson's diseaseChinese populationrisk factor
spellingShingle Ruinan Shen
Suzhen Lin
Lu He
Xue Zhu
Zhekun Zhou
Shengdi Chen
Ying Wang
Jianqing Ding
Association of Two Polymorphisms in CCL2 With Parkinson's Disease: A Case-Control Study
Frontiers in Neurology
CCL2
polymorphism
Parkinson's disease
Chinese population
risk factor
title Association of Two Polymorphisms in CCL2 With Parkinson's Disease: A Case-Control Study
title_full Association of Two Polymorphisms in CCL2 With Parkinson's Disease: A Case-Control Study
title_fullStr Association of Two Polymorphisms in CCL2 With Parkinson's Disease: A Case-Control Study
title_full_unstemmed Association of Two Polymorphisms in CCL2 With Parkinson's Disease: A Case-Control Study
title_short Association of Two Polymorphisms in CCL2 With Parkinson's Disease: A Case-Control Study
title_sort association of two polymorphisms in ccl2 with parkinson s disease a case control study
topic CCL2
polymorphism
Parkinson's disease
Chinese population
risk factor
url https://www.frontiersin.org/article/10.3389/fneur.2019.00035/full
work_keys_str_mv AT ruinanshen associationoftwopolymorphismsinccl2withparkinsonsdiseaseacasecontrolstudy
AT suzhenlin associationoftwopolymorphismsinccl2withparkinsonsdiseaseacasecontrolstudy
AT luhe associationoftwopolymorphismsinccl2withparkinsonsdiseaseacasecontrolstudy
AT xuezhu associationoftwopolymorphismsinccl2withparkinsonsdiseaseacasecontrolstudy
AT zhekunzhou associationoftwopolymorphismsinccl2withparkinsonsdiseaseacasecontrolstudy
AT shengdichen associationoftwopolymorphismsinccl2withparkinsonsdiseaseacasecontrolstudy
AT yingwang associationoftwopolymorphismsinccl2withparkinsonsdiseaseacasecontrolstudy
AT jianqingding associationoftwopolymorphismsinccl2withparkinsonsdiseaseacasecontrolstudy